Obstructive Sleep Apnea/Hypopnea Syndrome.

Area of Science:

• Sleep Medicine
• Pulmonology
• Cardiovascular Health

Background:

• Obstructive sleep apnea/hypopnea (OSA/H) is a prevalent disorder with diverse treatment modalities.
• Lifestyle modifications are crucial for managing upper airway instability during sleep.
• Treatment aggressiveness should align with the physiological and clinical severity of OSA/H.

Purpose of the Study:

• To outline therapeutic options for obstructive sleep apnea/hypopnea.
• To emphasize the importance of treating OSA/H to alleviate daytime sleepiness and hypoxemia.
• To highlight the association between OSA/H and cardiovascular diseases, suggesting a lower threshold for treatment in at-risk patients.

Main Methods:

• Assessment of OSA/H severity through its physiologic and clinical impact.
• Initial trial of continuous positive airway pressure (CPAP) for all patients requiring treatment.
• Evaluation of alternative therapies if CPAP is not tolerated long-term.

Main Results:

• CPAP therapy offers rapid and reliable alleviation of OSA/H symptoms.
• Non-positive pressure interventions cannot guarantee upper airway stabilization and may have adverse effects.
• Patient education is vital for successful OSA/H management and improved quality of life.

Conclusions:

• Continuous positive airway pressure (CPAP) is the recommended first-line treatment for obstructive sleep apnea/hypopnea.
• While CPAP is highly effective, patient education and management of side effects are essential for long-term adherence and outcomes.
• Early intervention for OSA/H, especially in patients with cardiovascular risk factors, is prudent due to strong disease associations.